Corvus Pharmaceuticals Inc (CRVS)
SG&A Expense Growth
-9.97%
Quarterly · Period ending:
CRVS SG&A Expense Growth
Latest reported-9.97%period ending
Latest reported-9.97%period ending
CRVS Quarterly SG&A Growth (QoQ) (0.00% → -9.97%)
Latest values, visible window
High-resolution chart · PNG
CRVS sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -9.9676% | |
| 62.511% | |
| 7.5543% | |
| -11.2694% | |
| -3.3212% | |
| 15.8611% | |
| 4.8205% | |
| 11.642% | |
| -16.3912% | |
| 31.8402% | |
| 3.5737% | |
| -3.5671% | |
| -16.4646% | |
| 24.8424% | |
| -24.7628% | |
| 0.8612% | |
| -9.6412% | |
| 14.3917% | |
| -1.6537% | |
| -5.8608% | |
| -32.862% | |
| 21.0193% | |
| -16.677% | |
| 10.8591% | |
| -6.3104% | |
| 23.254% | |
| 0.1192% | |
| -14.8512% | |
| 2.4255% | |
| 3.9251% | |
| 0.0721% | |
| 9.1231% | |
| 0.0787% | |
| 1.5994% | |
| 13.1162% | |
| -20.6958% | |
| 2.5% | |
| 28.423% | |
| -23.5103% | |
| 62.3095% | |
| 65.792% | |
| -13.8912% | |
| 97.1947% | |
| 85.3211% | |
| 12.7586% | |
| 158.5085% | |
| 0% |